<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Jullig M</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery.&lt;h4>Aim&lt;/h4>To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission.&lt;h4>Methods&lt;/h4>Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with tryp</pubmed_abstract><journal>PloS one</journal><pagination>e96489</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4011803</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes.</pubmed_title><pmcid>PMC4011803</pmcid><pubmed_authors>Middleditch M</pubmed_authors><pubmed_authors>Babor R</pubmed_authors><pubmed_authors>Yip S</pubmed_authors><pubmed_authors>Booth M</pubmed_authors><pubmed_authors>Beban G</pubmed_authors><pubmed_authors>Xu A</pubmed_authors><pubmed_authors>Jullig M</pubmed_authors><pubmed_authors>Smith G</pubmed_authors><pubmed_authors>Murphy R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lower fetuin-A, retinol binding protein 4 and several metabolites after gastric bypass compared to sleeve gastrectomy in patients with type 2 diabetes.</name><description>&lt;h4>Background&lt;/h4>Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery.&lt;h4>Aim&lt;/h4>To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission.&lt;h4>Methods&lt;/h4>Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with tryp</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014</publication><modification>2025-04-18T20:54:01.218Z</modification><creation>2019-03-26T23:24:39Z</creation></dates><accession>S-EPMC4011803</accession><cross_references><pubmed>24800810</pubmed><doi>10.1371/journal.pone.0096489</doi></cross_references></HashMap>